AU2016368527B2 - Bifidobacterium longum for treating obesity and associated metabolic disorders - Google Patents
Bifidobacterium longum for treating obesity and associated metabolic disorders Download PDFInfo
- Publication number
- AU2016368527B2 AU2016368527B2 AU2016368527A AU2016368527A AU2016368527B2 AU 2016368527 B2 AU2016368527 B2 AU 2016368527B2 AU 2016368527 A AU2016368527 A AU 2016368527A AU 2016368527 A AU2016368527 A AU 2016368527A AU 2016368527 B2 AU2016368527 B2 AU 2016368527B2
- Authority
- AU
- Australia
- Prior art keywords
- metabolic disorders
- bifidobacterium longum
- treating obesity
- associated metabolic
- obesity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
- A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15199660 | 2015-12-11 | ||
| EP15199660.0 | 2015-12-11 | ||
| PCT/EP2016/080454 WO2017097987A1 (en) | 2015-12-11 | 2016-12-09 | Bifidobacterium longum for treating obesity and associated metabolic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2016368527A1 AU2016368527A1 (en) | 2018-07-12 |
| AU2016368527B2 true AU2016368527B2 (en) | 2023-01-12 |
Family
ID=55070675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2016368527A Active AU2016368527B2 (en) | 2015-12-11 | 2016-12-09 | Bifidobacterium longum for treating obesity and associated metabolic disorders |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10973862B2 (enExample) |
| EP (1) | EP3386523B1 (enExample) |
| JP (1) | JP6843140B2 (enExample) |
| KR (1) | KR102819885B1 (enExample) |
| CN (1) | CN109069552B (enExample) |
| AU (1) | AU2016368527B2 (enExample) |
| BR (1) | BR112018011665A2 (enExample) |
| CA (1) | CA3006176C (enExample) |
| DK (1) | DK3386523T3 (enExample) |
| ES (1) | ES2760076T3 (enExample) |
| MX (1) | MX378890B (enExample) |
| PL (1) | PL3386523T3 (enExample) |
| RU (1) | RU2740096C2 (enExample) |
| WO (1) | WO2017097987A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016070151A1 (en) | 2014-10-31 | 2016-05-06 | Whole Biome. Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
| CN110392734A (zh) | 2017-02-28 | 2019-10-29 | 营养健康有限公司 | 可以有益地调节针对呼吸道病毒感染的免疫应答的长双歧杆菌 |
| EP3673044A1 (en) | 2017-08-25 | 2020-07-01 | University College Cork-National University of Ireland, Cork | Bifidobacterium longum for treating obesity and weight management |
| JP2020532515A (ja) | 2017-08-30 | 2020-11-12 | ペンデュラム セラピューティクス， インコーポレイテッド | マイクロバイオーム関連障害の処置のための方法および組成物 |
| CN117701424A (zh) * | 2018-04-11 | 2024-03-15 | 韩国生命工学研究院 | 具有肥胖预防或治疗效果的新的鼠李糖乳杆菌菌株及其用途 |
| CN113164526A (zh) | 2018-07-19 | 2021-07-23 | 潘德勒姆治疗公司 | 用于微生物植入的方法和组合物 |
| KR102224072B1 (ko) * | 2019-08-19 | 2021-03-10 | 주식회사 빙그레 | 면역 조절능력과 혈중콜레스테롤 감소 능력이 모두 뛰어난 비피도박테리엄 롱검 아종 균주 및 이의 용도 |
| WO2021180973A1 (en) | 2020-03-13 | 2021-09-16 | Precisionbiotics Group Limited | Bifidobacterium longum |
| CN113564069B (zh) * | 2021-05-28 | 2023-09-29 | 中山大学 | 一种长双歧杆菌、长双歧杆菌胞外多糖及其提取方法和应用 |
| CN115466689B (zh) * | 2022-02-09 | 2023-06-16 | 中国科学技术大学 | 用于预防和/或治疗代谢类疾病的益生菌组合物及其应用 |
| BG67720B1 (bg) * | 2022-03-18 | 2025-04-30 | "Ел Би Булгарикум" ЕАД | Щам bifidobacterium longum ssp. longum и бифидобактериален препарат с хиполипидемичен ефект, противовъзпалителен имуномодулиращ ефект и с намаляващ инсулиновата резистентност ефект |
| CN115637237B (zh) * | 2022-09-07 | 2024-09-17 | 辽宁贝克瑞生物科技有限公司 | 一株长双歧杆菌及其应用 |
| KR102789455B1 (ko) * | 2025-02-05 | 2025-04-04 | 주식회사 리스큐어바이오사이언시스 | 체지방 저감, 혈당 개선 및 근육 기능 강화 활성이 우수한 비피도박테리움 롱검 아종 롱검 lbmb322020 균주 및 이를 포함하는 대사성 질환 예방, 개선 또는 치료용 조성물 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010055499A2 (en) * | 2008-11-11 | 2010-05-20 | Alimentary Health Limited | Bifidobacterium longum |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1974734A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics for reduction of risk of obesity |
| US8557233B2 (en) | 2007-03-28 | 2013-10-15 | Alimentary Heath Limited | Probiotic bifidobacterium strains |
| JP2010526055A (ja) * | 2007-05-04 | 2010-07-29 | アリメンタリー・ヘルス・リミテッド | エキソ多糖 |
| EP2308499A1 (en) * | 2009-09-30 | 2011-04-13 | Nestec S.A. | Bifidobacterium longum ATCC BAA-999 (BL999) and weight control |
| CA2779418C (en) * | 2009-11-11 | 2018-03-20 | Alimentary Health Limited | Probiotic bifidobacterium strain |
| CA3092318A1 (en) * | 2012-09-20 | 2014-03-27 | Prothera, Inc. | Probiotic compositions and methods for the treatment of obesity and obesity-related conditions |
-
2016
- 2016-12-09 KR KR1020187016182A patent/KR102819885B1/ko active Active
- 2016-12-09 WO PCT/EP2016/080454 patent/WO2017097987A1/en not_active Ceased
- 2016-12-09 US US16/060,765 patent/US10973862B2/en active Active
- 2016-12-09 MX MX2018006905A patent/MX378890B/es unknown
- 2016-12-09 CN CN201680079991.4A patent/CN109069552B/zh active Active
- 2016-12-09 JP JP2018530515A patent/JP6843140B2/ja active Active
- 2016-12-09 BR BR112018011665A patent/BR112018011665A2/pt not_active Application Discontinuation
- 2016-12-09 EP EP16820183.8A patent/EP3386523B1/en active Active
- 2016-12-09 ES ES16820183T patent/ES2760076T3/es active Active
- 2016-12-09 RU RU2018119287A patent/RU2740096C2/ru active
- 2016-12-09 DK DK16820183.8T patent/DK3386523T3/da active
- 2016-12-09 CA CA3006176A patent/CA3006176C/en active Active
- 2016-12-09 AU AU2016368527A patent/AU2016368527B2/en active Active
- 2016-12-09 PL PL16820183T patent/PL3386523T3/pl unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010055499A2 (en) * | 2008-11-11 | 2010-05-20 | Alimentary Health Limited | Bifidobacterium longum |
Also Published As
| Publication number | Publication date |
|---|---|
| RU2018119287A (ru) | 2020-01-13 |
| WO2017097987A1 (en) | 2017-06-15 |
| DK3386523T3 (da) | 2020-01-06 |
| MX378890B (es) | 2025-03-10 |
| US20190111090A1 (en) | 2019-04-18 |
| CA3006176A1 (en) | 2017-06-15 |
| JP6843140B2 (ja) | 2021-03-17 |
| CA3006176C (en) | 2023-10-31 |
| CN109069552B (zh) | 2023-01-24 |
| CN109069552A (zh) | 2018-12-21 |
| MX2018006905A (es) | 2018-08-24 |
| RU2740096C2 (ru) | 2021-01-11 |
| JP2018536427A (ja) | 2018-12-13 |
| PL3386523T3 (pl) | 2020-03-31 |
| KR20180083352A (ko) | 2018-07-20 |
| AU2016368527A1 (en) | 2018-07-12 |
| RU2018119287A3 (enExample) | 2020-06-30 |
| EP3386523B1 (en) | 2019-10-09 |
| EP3386523A1 (en) | 2018-10-17 |
| US10973862B2 (en) | 2021-04-13 |
| BR112018011665A2 (pt) | 2018-12-04 |
| KR102819885B1 (ko) | 2025-06-12 |
| ES2760076T3 (es) | 2020-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016368527B2 (en) | Bifidobacterium longum for treating obesity and associated metabolic disorders | |
| HUS2500022I1 (hu) | Terápiás ellenanyagok és alkalmazásaik | |
| DK3223835T3 (en) | Intestinal microbiota and gvhd | |
| EP3212226A4 (en) | Compositions and methods of use for treating metabolic disorders | |
| EP3174894A4 (en) | Compositions and methods of use for treating metabolic disorders | |
| EP3183005A4 (en) | Methods and compositions for the treatment of metabolic disorders | |
| EP3212191A4 (en) | Treatment for depression and depressive disorders | |
| PL3194567T3 (pl) | Probiotyczne szczepy bifidobacterium adolescentis | |
| PL3387156T3 (pl) | Lactobacillus casei do leczenia otyłości i powiązanych zaburzeń metabolicznych | |
| EP3092008A4 (en) | Skin probiotic | |
| EP3189036A4 (en) | Compositions and methods for treating proliferation disorders | |
| IL258005A (en) | Methods and materials for gene therapy for beta-4,1-en.-acetylgalactosaminyltransferase 2 | |
| PT3277295T (pt) | Composição para o tratamento de um estado metabólico patogénico da flora intestinal e de doenças derivadas | |
| EP3122872A4 (en) | Compositions and methods for treating type 1 and type 2 diabetes and related disorders | |
| EP3285805A4 (en) | Therapeutic antibodies and uses thereof | |
| EP3538075A4 (en) | GENE THERAPY STRUCTURES AND PROCESSES | |
| EP3217992A4 (en) | Probiotic therapeutic applications | |
| EP3142699A4 (en) | Compositions and methods for treating metabolic disorders | |
| IL263218A (en) | Compounds and methods for microbiotic therapy | |
| EP3149035A4 (en) | Therapeutic compositions including therapeutic small molecules and uses thereof | |
| EP3107546A4 (en) | Therapeutic methods employing noribogaine and related compounds | |
| EP3185873A4 (en) | Pharmaceutical composition and methods | |
| EP3166626A4 (en) | Materials and methods for treating disorders associated with sulfatase enzymes | |
| EP3258930A4 (en) | Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders | |
| EP3262065A4 (en) | Methods and compositions for treating dystroglycanopathy disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HB | Alteration of name in register |
Owner name: PRECISIONBIOTICS GROUP LIMITED Free format text: FORMER NAME(S): ALIMENTARY HEALTH LIMITED |
|
| FGA | Letters patent sealed or granted (standard patent) |